Patents invented by our scientists

No. Publication Nr. Title
1 WO2017135901 Heterocyclic compounds, methods of synthesis and uses thereof
2

EP3194399

US2017260187

New agents for treating neurogenic inflammation and neuropathic hyperalgesia related disorders
3 WO2017153789

Benzo[b]thiophene derivatives and their use for the inhibition of fibroblast growth factor receptor kinases (FGFRs) for the use of neo- and hyperplasia therapies

Examples: xlsx

4 US20160113989 Anticancer and immunomodulating molecules and fractions containing said molecules, and process for preparing said fractions and said molecules from fermented vegetal material, and their uses
5 WO2016042349 New agents for treating neurogenic inflammation and neuropathic hyperalgesia related disorders
6

WO2016041972

EP3194366

US2017240522

Benzothiophene, benzyloxybenzylidene and indoline derivatives useful for the treatment of tuberculosis

Examples: xlsx

7 WO2016131789 Benzopyrrolidone derivatives possessing antiviral and anticancer properties
8

WO2014031937

CA2882733

EP2887943

MX2015002270

JP2015526479

US20140057911

EA201590417

Novel 4,6-disubstituted aminopyrimidine derivatives
9

WO2011077171

US9040529

EP2516405

DK2516405

ES2558132

JP5857211

4-Phenylamino-pyrimidine derivatives having protein kinase inhibitor activity
10

WO2015019121

US2016194291

CA2920754

EP3030550

JP2016529250

Styryl quinazoline derivatives as pharmaceutically active agents

Examples: xlsx

11

WO2015022437

EP2837626

Indolinone derivatives as GRK5 modulators
12

WO2011045084

US9169241

CN102574804 

EP2462117

HK1171017

US8685971

AU2010306003

Quinolinyloxyphenylsulfonamides
13

WO2014106762

US20150368209

EP2941428

4-Pyrimidinylamino-benzenesulfonamide derivatives and their use for the inhibition of polo-like kinase 1 (PLK1) for the treatment of cancer and their use for the treatment of bacterial infections

Examples: xlsx

14 WO2014106763

Pyridopyrazines as anticancer agents

Examples: xlsx

15

WO2011077171

DK2516405

EP2516405

ES2558132

US9040529

JP2013515047

4-Phenylamino-pyrimidine derivatives having protein kinase inhibitor activity
16

WO2009127417

AU2009237938

CA2718538

CN102131783

EP2262772

IL208103

JP5746015

KR101325237

MX2010011224

RU2010146474

US9206130

ES2391373

Quinoline derivatives as axl kinase inhibitors
17

WO2012018370

EP2600721

US20120164132

Anticancer and immunomodulating molecules and fractions containing said molecules, and process for preparing said fractions and said molecules from fermented vegetal material, and their uses
18

WO2009104026

US20110015214

EP2257554

Tricyclic benzo[4,5]thieno-[2,3-d]pyrimidine-4-yl-amin derivatives, their salts, process for producing the compounds and their pharmaceutical use

Examples: xlsx sdf(zip)

19

WO2010100515

US20110318409

EP2403513

Fractions of wheat germ ferment
20 WO2009104027 Therapeutic application of triciclic aromatic and saturated benzo(4,5)thieno-(2,3-d)pyrimidine derivates, as well as their therapeutically acceptable salts
21

WO2006021458

US20080187575

CA2578122

EP1786781

JP2008510766

Pyrimidine Derivatives
22

WO2007060028

CA2593718

EP1833832

US20080207677

Napthyridine Compounds As Rock Inhibitors
23

WO2005105804

US20080214583

CA2564277

AT462706

AU2005238287

CN1972946

EP1756110

HU0400891

JP2007534737

KR20070047737

RU2006141393

7h-Pyrrolo[2,3-d]pyrimidine derivatives, as well as their therapeutically acceptable salts, pharmaceutical preparations containing them and process for production the active agent
24

WO2005023818

AU2004270394

CA2572750

EP1670804

US20070275962

Heterobicyclic Compounds as Pharmaceutically Active Agents

Examples: xlsx

25

WO0156553

AT308982

AU4057801

EP1255541

ES2250363

US2003203969

DE60114772

Pharmaceutically active aromatic guanylhydrazones
26 WO2006089874 Benzo[2,3]azepino[4,5-b]indol-6-ones
27 US20040171603 Novel therapeutic targets for the treatment of mycobacterial infections and compounds useful therefor
28

WO02094796

AU2002312927

Benzo[g]quinoxaline derivatives as effective compounds against infectious diseases
29

WO0220527

AU8613101

HU0003554

Soluble compounds for the inhibition of multidrug resistance and pharmaceutical compositions thereof
30 US6331555 Treatment of platelet derived growth factor related disorders such as cancers
31 HU226567 Process for producing pharmaceutical compositions containing heptapeptide somatostatin derivatives of neurogene- and non-neurogene-antiflogistic and analgesic activity and peptidomimetica
32 AT307145 Use of phenylhydrazone derivatives as antinflammatory or analgetic agents
33 CA2269995 Process for producing pharmaceutical compositions containing heptapeptide somatostatin derivatives of neurogene- and non-neurogene-antiflogistic and analgesic activity and peptidomimetica
34

EP0952159

DK0952159

DE69927735

ES2251803

Use of phenylhydrazone derivatives as antinflammatory or analgetic agents
35

JP2000001439

KR19990083438

Pharmaceutical compositions possessing neurogenic or non-neurogenic anti-inflammatory as well as analgetic effects
36 US6689813 Process for producing pharmaceutical compositions containing heptapeptide somatostatin derivatives of neurogene- and non-neurogene-antiflogistic and analgesic activity and peptidomimetica
37 HU214061 Process for producing phenylamino-acetly-hydrazide derivatives and pharmaceutical compositions containing the said compounds with tumor growth and enzyme-activity inhibiting effect
38

WO9519169

AT192925

AU690958

CA2180658

CN1065744

DE69517054

DK0804191

EP0804191

GR3034215

IL112277

PT804191

US5990141

ES2149966

Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth receptor
39 HU209498 Process for producing 1,4-diazepino/3,4-b/quinasoline-3,7-dione derivatives and pharmaceutically acceptable salts thereof
40

WO9316064

AU3573893

Coumarin derivatives and their analogues inhibiting cell proliferation and tumour growth, pharmaceutical compositions containing them and process for preparing same
41 HUT63843 Process for producing new kumarin derivatives and their analogs inhibiting mammal cell proliferation and tumour growth, as well as pharmaceutical comkpositions comprising such compounds
42 HU208975 Process for producing imidazo/5,1-b/ quinazolin-9-one derivatives and pharmaceutically acceptable salts thereof, as well as thrombocyta aggregation inhibiting pharmaceutical compositions comprising such active ingredients
43

WO2014180544

EP2801573

Hydantoine derivatives as CD38 inhibitors